Christoph Parthier

Title: Christoph Parthier: Innovator in Glutaminyl Cyclase Research

Introduction

Christoph Parthier is a notable inventor based in Halle/Saale, Germany. He has made significant contributions to the field of biochemistry, particularly in the study of glutaminyl cyclase. With a total of 3 patents to his name, Parthier's work has implications for understanding and potentially treating various health conditions.

Latest Patents

Parthier's latest patents include groundbreaking research on the crystal structure of glutaminyl cyclase. This patent details novel crystal structures of both human and murine glutaminyl cyclase (QC, EC 2.3.2.5), along with methods for preparing these crystals. The research also explores the use of these crystal structures for identifying inhibitors of human and murine glutaminyl cyclase. Another significant patent focuses on the crystal structure of isoglutaminyl cyclase, which describes a crystal comprising human isoglutaminyl cyclase characterized by a space group of P1211 and specific unit cell dimensions.

Career Highlights

Christoph Parthier is currently employed at Probiodrug AG, where he continues to advance his research in the field. His work has been instrumental in enhancing the understanding of cyclases and their potential therapeutic applications.

Collaborations

Parthier collaborates with esteemed colleagues such as Stephan Schilling and Jens-Ulrich Rahfeld, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Christoph Parthier's contributions to the field of biochemistry, particularly through his patents on glutaminyl and isoglutaminyl cyclases, highlight his role as a leading inventor in this area. His ongoing research at Probiodrug AG promises to further advance our understanding of these important enzymes.